COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,430 Articles (22,835 medRxiv, 8,595 bioRxiv)

Most recent first Previous |  Page 40: Articles 391-400  | Next

Evolution and Viral Properties of the SARS-CoV-2 BA.3.2 Subvariant
Jule, Z., Romer, C., Hossen, T., Sviridchik, V., Reedoy, K., Ganga, Y., Norman, A., Silangwe, S., Karim, F., Kekana, D., Mahlangu, B., Mnguni, A., Nzimande, A., Stock, N., Bernstein, M., Gosnell, B., Moosa, Y., Wolter, N., Khan, K., Neher, R. A., Sigal, A.
10.1101/2025.10.28.25338622 — Posted: 2025-10-29
Recovery from post-COVID-19 condition and associated factors: the PRIME post-COVID study
Pagen-Arets, D. M. E., van Bilsen, C. J. A., Wijnen, S. M. C. E., den Heijer, C. D. J., Hoebe, C. J. P. A., Dukers-Muijrers, N. H. T. M.
10.1101/2025.10.28.25338941 — Posted: 2025-10-29
SwitchClass: dissecting attenuated and escalated molecular features via a label-switch classification framework
Xiao, D., Yang, P.
10.1101/2025.10.29.685265 — Posted: 2025-10-29
A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
Plaut, S.
10.1101/2025.10.23.25338705 — Posted: 2025-10-28
Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients
Frölke, S., Amirkhan, K., van der Bom-Baylon, N., van Gils, M., Claireaux, M., Geerlings, S., de Vries, R., Sanders, J.-S., Hilbrands, L., Diavatopoulos, D., Messchendorp, L., van Aalderen, M., Remmerswaal, E., Bemelman, F.
10.1101/2025.10.26.25338845 — Posted: 2025-10-28
Epidemiology and treatment trends in lumbar and cervical spinal canal stenosis beyond the COVID-19 pandemic - a nationwide analysis
Krämer, C., Almahozi, A., Wasilewski, D., Mark-Sargut, C. S., Alsolivany, J., Dengler, N. F., Rösler, J., Faust, K., Sargut, T. A.
10.1101/2025.10.26.25338840 — Posted: 2025-10-28
A multicentre study to predict COVID-19 outbreaks in long-term care homes using wastewater surveillance and environmental surface sampling for SARS-CoV-2
Moggridge, J. A., Acharya, K., MacFadden, D. R., Wong, A., Kassen, R., Nott, C., Ybazeta, G., Guttman, D. S., Castellani, L., Fralick, M.
10.1101/2025.10.20.25337094 — Posted: 2025-10-28
Polypharmacy and Proton Pump Inhibitor Use Independently Predict One-Year Mortality in Critical COVID-19: An Explainable AI-Based Survival Analysis
Hjärtström, M., Didriksson, I., Spangfors, M., Friberg, H., Jakobsson, A., Frigyesi, A.
10.1101/2025.10.27.25338863 — Posted: 2025-10-28
Comparing Wastewater-Based and Case-Based Rt Estimates of SARS-CoV-2 Transmission in Georgia Using Generalized Linear Mixed Models
Edmunds, S. H., Landsittel, D., Ajelli, M., Litvinova, M.
10.1101/2025.10.24.25338734 — Posted: 2025-10-27
Structural constraints acting on the SARS-CoV-2 spike protein reveal limited space for viral adaptation
Herzig, J. C., Magwira, M. L., Lovell, S. C.
10.1101/2025.10.27.684767 — Posted: 2025-10-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).